T-NON-HODGKIN LYMPHOMA
Clinical trials for T-NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for T-NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells target tough blood cancers in early trial
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for adults and children with T-cell leukemia or lymphoma that has come back after a stem cell transplant. Doctors take a patient's or their donor's immune cells, modify them in a lab to better target the cancer, and infuse them…
Matched conditions: T-NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists re-engineer Patient's own cells to hunt deadly blood cancers
Disease control Recruiting nowThis early-phase study is testing a new cell therapy for adults and children with aggressive T-cell leukemias or lymphomas that have returned or not responded to standard treatments. Doctors take a patient's own immune cells, genetically modify them in a lab to better recognize a…
Matched conditions: T-NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC